Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2016 Volume 12 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2016 Volume 12 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats

  • Authors:
    • Mi Young Jung
    • Joo Wan Kim
    • Ki Young Kim
    • Seong Hun Choi
    • Sae Kwang Ku
  • View Affiliations / Copyright

    Affiliations: Department of Anatomy and Histology, College of Oriental Medicine, Daegu Haany University, Gyeongsan‑si, Gyeongsangbuk‑do 712‑715, Republic of Korea, Glucan Corp. Research Institute, Marine Bio‑Industry Development Center, Busan 619‑912, Republic of Korea
    Copyright: © Jung et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1251-1262
    |
    Published online on: June 27, 2016
       https://doi.org/10.3892/etm.2016.3485
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the protective effects of Polycan, a β-glucan from Aureobasidium pullulans SM‑2001, in a rat model of ovariectomy-induced osteoporosis. Ovariectomized (OVX) rats were orally administered 31.25, 62.5 or 125 mg/kg/day Polycan for 126 days, and alterations in body weight, bone mineral content, bone mineral density, failure load, histological profiles and histomorphometric indices were analyzed. In particular, serum levels of osteocalcin, bone-specific alkaline phosphatase (bALP), calcium and phosphorus, and the urine deoxypyridinoline/creatinine ratio, were measured. Furthermore, the femur, tibia and lumbar vertebrae were harvested from all rats, and histomorphometrical analyses were conducted in order to assess the mass and structure of the bones, and the rates of bone resorption and formation. One group of rats was treated with alendronate, which served as the reference drug. The results of the present study suggested that Polycan treatment was able to inhibit ovariectomy-induced alterations in bone resorption and turnover in a dose‑dependent manner. In addition, the serum expression levels of bALP and all histomorphometrical indices for bone formation were markedly increased in the Polycan-treated groups. These results indicated that Polycan was able to preserve bone mass and strength, and increase the rate of bone formation in OVX rats; thus suggesting that Polycan may be considered a potential effective anti-osteoporosis agent.
View Figures

Figure 1

Figure 2

View References

1 

Sakai A, Nishida S, Okimoto N, Okazaki Y, Hirano T, Norimura T, Suda T and Nakamura T: Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice. Bone. 23:443–451. 1998. View Article : Google Scholar : PubMed/NCBI

2 

Madureira MM, Ciconelli RM and Pereira RM: Quality of life measurements in patients with osteoporosis and fractures. Clinics (Sao Paulo). 6:1315–1320. 2012. View Article : Google Scholar

3 

Melton LJ III, Chrischilles EA, Cooper C, Lane AW and Riggs BL: How many women have osteoporosis? JBMR Anniversary Classic. JMBR, Volume 7, Number 9, 1992. J Bone Miner Res. 20:886–892. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Rodan GA and Martin TJ: Therapeutic approaches to bone diseases. Science. 289:1508–1514. 2000. View Article : Google Scholar : PubMed/NCBI

5 

Chen JS and Sambrook PN: Antiresorptive therapies for osteoporosis: A clinical overview. Nat Rev Endocrinol. 8:81–91. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Gowen M, Emery JG and Kumar S: Emerging therapies for osteoporosis. Expert Opin Emerg Drugs. 5:1–43. 2000.

7 

Girotra M, Rubin MR and Bilezikian JP: Anabolic agents for osteoporosis: What is their likely place in therapy? Treat Endcrinol. 5:347–358. 2006. View Article : Google Scholar

8 

Kalu DN: The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:175–191. 1991. View Article : Google Scholar : PubMed/NCBI

9 

Frost HM and Jee WS: On the rat model of human osteopenias and osteoporoses. Bone Miner. 18:227–236. 1992. View Article : Google Scholar : PubMed/NCBI

10 

Wronski TJ, Yen CF and Scott KS: Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J Bone Miner Res. 6:387–394. 1991. View Article : Google Scholar : PubMed/NCBI

11 

Kimmel DB, Recker RR, Gallagher JC, Vaswani AS and Aloia JF: A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner. 11:217–235. 1990. View Article : Google Scholar : PubMed/NCBI

12 

Ke HZ, Foley GL, Simmons HA, Shen V and Thompson DD: Long-term treatment of lasofoxifene preserves bone mass and bone strength and dose not adversely affect the uterus in ovariectomized rats. Endocrinology. 145:1996–2005. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Manolagas SC, Kousteni S and Jilka RL: Sex steroids and bone. Recent Prog Horm Res. 57:385–409. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC and Liberman UA: Alendronate Phase III Osteoporosis Treatment Study Group: Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 350:1189–1199. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Strewler GJ: Decimal point-osteoporosis therapy at the 10-year mark. N Engl J Med. 350:1172–1174. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA and Hayes WC: Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res. 8:871–879. 1993. View Article : Google Scholar : PubMed/NCBI

17 

McClung MR, Wasnich RD, Hosking DJ, Christiansen C, Ravn P, Wu M, Mantz AM, Yates J, Ross PD and Santora AC II: Early Postmenopausal Intervention Cohort Study: Prevention of postmenopausal bone loss: Six-year results from the early postmenopausal intervention cohort study. J Clin Endocrinol Metab. 89:4879–4885. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Bell NH: Advances in the treatment of osteoporosis. Curr Drug Targets Immune Endocr Metabol Disord. 1:93–102. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Boivin G and Meunier PJ: The mineralization of bone tissue: A forgotten dimension in osteoporosis research. Osteoporos Int. 14(Suppl 3): S19–S24. 2003.PubMed/NCBI

20 

Shin HD, Yang KJ, Park BR, Son CW, Jang HJ and Ku SK: Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition. 23:853–860. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Song HB, Park DC, Do GM, Hwang SL, Lee WK, Kang HS, Park BR, Jang HJ, Son CW, Park EK, et al: Effect of exopolymers of Aureobasidium pullulans on improving osteoporosis induced in ovariectomized mice. J Microbiol Biotechnol. 16:37–45. 2006.

22 

Park SO and Kim JM: Functional food for immune regulation - beta-glucan. Food Science and Industry. 45:39–47. 2012.

23 

Estrada A, Yun CH, Van Kessel A, Li B, Hauta S and Laarveld B: Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol Immunol. 41:991–998. 1997. View Article : Google Scholar : PubMed/NCBI

24 

Bell S, Goldman VM, Bistrian BR, Arnold AH, Ostroff G and Forse RA: Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr. 39:189–202. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Seo HP, Kim JM, Shin HD, Kim TK, Chang HJ, Park BR and Lee JW: Production of β-1,3/1,6-glucan by Aureobasidium pullulans SM-2001. Korean J Bitechnol Bioeng. 17:376–380. 2002.

26 

Lee HS, Cho HR, Moon SB, Shin HD, Yang KJ, Park BR, Jang HJ, Kim LS and Ku SK: Effect of β-glucan from Aureobasidium pullulans on rat rib fracture healing. Lab Anim Res. 24:39–44. 2008.

27 

Han SY, Lee JR, Kwon YK, Jo MJ, Park SJ, Kim SC, Lee HS and Ku SK: Ostreae testa prevent ovariectomy-induced bone loss in mice by osteoblast activations. J Ethnopharmacol. 114:400–405. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM and Recker RR: Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 2:595–610. 1987. View Article : Google Scholar : PubMed/NCBI

29 

Lorden JF and Caudle A: Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav Toxicol Teratol. 8:509–519. 1986.PubMed/NCBI

30 

Li B and Yu S: Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull. 26:780–786. 2003. View Article : Google Scholar : PubMed/NCBI

31 

Ladizesky MG, Cutrera RA, Boggio V, Somoza J, Centrella JM, Mautalen C and Cardinali DP: Effect of melatonin on bone metabolism in ovariectomized rats. Life Sci. 70:557–565. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Shim JG, Yeom SH, Kim HJ, Choi YW, Lee DI, Song KY, Kwon SH and Lee MW: Bone loss preventing effect of Sophorae Fructus on ovariectomized rats. Arch Pharm Res. 28:106–110. 2005. View Article : Google Scholar : PubMed/NCBI

33 

Xu M, Dick IM, Day R, Randall D and Prince RL: Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats. Am J Chin Med. 31:87–101. 2003. View Article : Google Scholar : PubMed/NCBI

34 

Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H and Yeh JK: Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats. J Nutr Sci Vitaminol (Tokyo). 52:1–8. 2006. View Article : Google Scholar : PubMed/NCBI

35 

Pavlik M: Measuring bone mineral content. Orthop Nurs. 10:39–43. 1991. View Article : Google Scholar : PubMed/NCBI

36 

Tanaka S, Shimizu M, Debari K, Furuya R, Kawawa T and Sasaki T: Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats. Anat Rec. 262:203–212. 2001. View Article : Google Scholar : PubMed/NCBI

37 

Syed Z and Khan A: Bone densitometry: Applications and limitations. J Obstet Gynaecol Can. 24:476–484. 2002. View Article : Google Scholar : PubMed/NCBI

38 

Diez F: Guidelines for the diagnosis of osteoporosis by densitometric methods. J Manipulative Physiol Ther. 25:403–415. 2002. View Article : Google Scholar : PubMed/NCBI

39 

Bilston LE, Little DG, Smith NC, Williams P and Briody J: Zoledronic acid improves the mechanical properties of normal and healing bone. Clin Biomech (Bristol, Avon). 17:716–718. 2002. View Article : Google Scholar : PubMed/NCBI

40 

Heikkinen T, Puoliväli J and Tanila H: Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice. Exp Gerontol. 39:1277–1283. 2004. View Article : Google Scholar : PubMed/NCBI

41 

Weinreb M, Patael H, Preisler O and Ben-Shemen S: Short-term healing kinetics of cortical and cancellous bone osteopenia induced by unloading during the reloading period in young rats. Virchows Arch. 431:449–452. 1997. View Article : Google Scholar : PubMed/NCBI

42 

Verhaeghe J, Oloumi G, van Herck E, van Bree R, Dequeker J, Einhorn TA and Bouillon R: Effects of long-term diabetes and/or high-dose 17 beta-estradiol on bone formation, bone mineral density, and strength in ovariectomized rats. Bone. 20:421–428. 1997. View Article : Google Scholar : PubMed/NCBI

43 

Gal-Moscovici A, Gal M and Popovtzer MM: Treatment of osteoporotic ovariectomized rats with 24,25(OH)2D3. Eur J Clin Invest. 35:375–379. 2005. View Article : Google Scholar : PubMed/NCBI

44 

Andersson N, Lindberg MK, Ohlsson C, Andersson K and Ryberg B: Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice. J Endocrinol. 170:529–537. 2001. View Article : Google Scholar : PubMed/NCBI

45 

da Paz LH, de Falco V, Teng NC, dos Reis LM, Pereira RM and Jorgetti V: Effect of 17beta-estradiol or alendronate on the bone densitometry, bone histomorphometry and bone metabolism of ovariectomized rats. Braz J Med Biol Res. 34:1015–1022. 2001. View Article : Google Scholar : PubMed/NCBI

46 

Broulik PD, Rosenkrancová J, Růzicka P and Sedlácek R: Effect of alendronate administration on bone mineral density and bone strength in castrated rats. Horm Metab Res. 37:414–418. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jung MY, Kim JW, Kim KY, Choi SH and Ku SK: Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats. Exp Ther Med 12: 1251-1262, 2016.
APA
Jung, M.Y., Kim, J.W., Kim, K.Y., Choi, S.H., & Ku, S.K. (2016). Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats. Experimental and Therapeutic Medicine, 12, 1251-1262. https://doi.org/10.3892/etm.2016.3485
MLA
Jung, M. Y., Kim, J. W., Kim, K. Y., Choi, S. H., Ku, S. K."Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats". Experimental and Therapeutic Medicine 12.3 (2016): 1251-1262.
Chicago
Jung, M. Y., Kim, J. W., Kim, K. Y., Choi, S. H., Ku, S. K."Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats". Experimental and Therapeutic Medicine 12, no. 3 (2016): 1251-1262. https://doi.org/10.3892/etm.2016.3485
Copy and paste a formatted citation
x
Spandidos Publications style
Jung MY, Kim JW, Kim KY, Choi SH and Ku SK: Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats. Exp Ther Med 12: 1251-1262, 2016.
APA
Jung, M.Y., Kim, J.W., Kim, K.Y., Choi, S.H., & Ku, S.K. (2016). Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats. Experimental and Therapeutic Medicine, 12, 1251-1262. https://doi.org/10.3892/etm.2016.3485
MLA
Jung, M. Y., Kim, J. W., Kim, K. Y., Choi, S. H., Ku, S. K."Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats". Experimental and Therapeutic Medicine 12.3 (2016): 1251-1262.
Chicago
Jung, M. Y., Kim, J. W., Kim, K. Y., Choi, S. H., Ku, S. K."Polycan, a β-glucan from Aureobasidium pullulans SM-2001, mitigates ovariectomy-induced osteoporosis in rats". Experimental and Therapeutic Medicine 12, no. 3 (2016): 1251-1262. https://doi.org/10.3892/etm.2016.3485
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team